Hudson Value Partners’s Merck MRK Stock Holding History
Bought
Maintained
Sold
Other funds holding MRK
LMFP
ATO
QP
Hudson Value Partners's MRK Position: Q2 2026 in Review
Hudson Value Partners reduced its Merck (MRK) stake by 3% in Q2 2026, selling an estimated $206K and leaving 57,439 shares worth $7.38M. The position accounts for 1.85% of the portfolio, ranked #18.
Hudson Value Partners first reported a position in MRK in Q4 2020 and has held it in 23 quarters since. The position peaked at $7.48M in Q1 2025. 1,299 funds tracked by Wall St. Rank hold MRK as of Q2 2026.
- Hudson Value Partners held 57,439 shares of Merck worth $7.38M as of Q2 2026.
- Hudson Value Partners sold 1,758 Merck shares in Q2 2026, an estimated $206K.
- Merck made up 1.85% of Hudson Value Partners's portfolio in Q2 2026, its #18 holding.
- Hudson Value Partners first reported a position in Merck in Q4 2020 and has held it in 23 quarters since.
- Hudson Value Partners's Merck position peaked at $7.48M in Q1 2025.
- 1,299 funds tracked by Wall St. Rank held Merck as of Q2 2026.
Based on Hudson Value Partners's 13F filing for Q2 2026, filed 10 Jul 2026.